AFP and ovarian adenocarcinoma: Experiments with radioactively labeled an AIF (AFP-3BC) have confirmed that they selectively accumulate in cancer cells and that AFP-3BC loaded with drugs binds to human breast MCF7 cells and ovarian adenocarcinoma SKOV3 cells, suppressing the proliferation of these cancer cells.